InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,737.60
(
0.31%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
83.06
(
0.81%
)
Bitcoin
62,679.64
(
2.00%
)
Post# of 675
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

senderos

Send PM Follow Ignore
Followers 88
Posts 7770
Boards Moderated 0
Alias Born 02/28/2004

senderos

Re: StockRacer87 post# 246

Saturday, 11/25/2017 8:33:04 AM

Saturday, November 25, 2017 8:33:04 AM

Post# of 675
Which trial? I see that we should get top line results for Keyzilen during 1st quarter of 2018, and we have a business update and CC next week. But I don't see a drug to be reported on next week.

Ah, phase 3 results for HEALOS trial for AM-111 is supposed to be reported in Q4 2017.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!